Merck chooses London for its new HQ

By Catherine Sturman
Despite the uncertainties surrounding Brexit, Merck is set to open its new headquarters in London, bringing over 100 new jobs to the capital. “We bel...

Despite the uncertainties surrounding Brexit, Merck is set to open its new headquarters in London, bringing over 100 new jobs to the capital.

“We believe London to be a unique bioscience centre of excellence and a key component of the established golden triangle for academic science of London-Oxford-Cambridge,” commented Louise Houson, Managing Director for Merck in the UK and Ireland.

Business Secretary Greg Clark has said: “We are an open, flexible economy, built on trade and engagement with the world.

We have a competitive business environment with a deserved reputation for being a dependable and confident place to do business, thanks to our high standards, respected institutions and a reliable rule of law.”

Related stories

With 150 new researchers, Merck is set to extend its clinical presence within Europe through the move from Hertfordshire to London. In addition to encompassing over 500 new staff in various roles, the move will see the pharmaceutical giant further its operations across Europe.

Life sciences is one sector the UK government is looking at with increased interest through its Industrial Strategy. Other sectors include AI, construction and the automotive sector. Such investments will therefore see the UK retain its position as a centre of excellence within the healthcare and research industry upon its upheaval from the European Union.

The paper signifies the UK’s long-term ambitions within research and development and will provide vital economic growth.

“The investment presents a major opportunity for us to work in collaboration with the UK government to build on the forward thinking and ambitious industrial strategy white paper being published," added Houson.

 

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare